These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3242584)

  • 1. Chronic dose urinary and serum pharmacokinetics of norfloxacin in the elderly.
    Kelly JG; Deaney NB; Lavan J; Noel J
    Br J Clin Pharmacol; 1988 Dec; 26(6):787-90. PubMed ID: 3242584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of norfloxacin in the aged.
    MacGowan AP; Greig MA; Clarke EA; White LO; Reeves DS
    J Antimicrob Chemother; 1988 Nov; 22(5):721-7. PubMed ID: 3209530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of norfloxacin in dogs after single intravenous and single and multiple oral administrations of the drug.
    Brown SA; Cooper J; Gauze JJ; Greco DS; Weise DW; Buck JM
    Am J Vet Res; 1990 Jul; 51(7):1065-70. PubMed ID: 2389884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of norfloxacin in chronic renal failure.
    Arrigo G; Cavaliere G; D'Amico G; Passarella E; Broccali G
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of norfloxacin in the elderly.
    Lepage JY; Caillon J; Malinowsky JM; Lequerré S; Cozian A; Le Normand Y; Potel G; Drugeon H; Baron D
    Fundam Clin Pharmacol; 1991; 5(3):203-8. PubMed ID: 1937349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bioavailability of norfloxacin tablets based on blood and urine data.
    Nada AH; Sharaf MA; El Gholmy ZA; Khalafallah NM
    Med Princ Pract; 2007; 16(6):426-31. PubMed ID: 17917441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics and clinical studies of norfloxacin in the pediatric field].
    Motohiro T; Yoshinaga Y; Tsumura N; Oki S; Sasaki H; Aramaki M; Oda K; Kawakami A; Koga T; Shimada Y
    Jpn J Antibiot; 1990 May; 43(5):901-17. PubMed ID: 2202843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of pefloxacin and its desmethyl metabolite into the uroepithelium after a 800-mg single oral dose in human patients.
    Moreau JL; Royer-Morrot MJ; Lozniewski A; Trackoen G; Delavault P; Royer RJ
    Eur J Clin Pharmacol; 1996; 49(5):401-5. PubMed ID: 8866637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetic profiles of two norfloxacin formulations after oral administration in rabbits.
    Park SC; Yun HI; Oh TK
    J Vet Med Sci; 1998 May; 60(5):661-3. PubMed ID: 9637308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers.
    Frydman AM; Le Roux Y; Lefebvre MA; Djebbar F; Fourtillan JB; Gaillot J
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():65-79. PubMed ID: 3458699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and tissue fluid norfloxacin concentrations after oral administration of the drug to healthy dogs.
    Walker RD; Stein GE; Budsberg SC; Rosser EJ; MacDonald KH
    Am J Vet Res; 1989 Jan; 50(1):154-7. PubMed ID: 2919820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of pharmacokinetics of norfloxacin following oral administration of curcumin in rabbits.
    Pavithra BH; Prakash N; Jayakumar K
    J Vet Sci; 2009 Dec; 10(4):293-7. PubMed ID: 19934593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norfloxacin disposition after sequentially increasing oral doses.
    Swanson BN; Boppana VK; Vlasses PH; Rotmensch HH; Ferguson RK
    Antimicrob Agents Chemother; 1983 Feb; 23(2):284-8. PubMed ID: 6220672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial.
    Pimentel FL; Dolgner A; Guimarães J; Quintas M; Mário-Reis J
    J Chemother; 1998 Apr; 10(2):122-7. PubMed ID: 9603637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Norfloxacin concentration in human prostatic tissue after 3 days administration].
    Morita M; Hasuda A
    Hinyokika Kiyo; 1989 Jul; 35(7):1261-5. PubMed ID: 2478009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of norfloxacin (MK 366) in patients with impaired kidney function--some preliminary results.
    Hughes PJ; Webb DB; Asscher AW
    J Antimicrob Chemother; 1984 May; 13 Suppl B():55-7. PubMed ID: 6234276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of norfloxacin and trimethoprim for the treatment of elderly patients with urinary tract infection.
    Ewer TC; Bailey RR; Gilchrist NL; Aitken JM; Sainsbury R
    N Z Med J; 1988 Aug; 101(852):537-9. PubMed ID: 3045717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basic and clinical studies on norfloxacin in the pediatric field].
    Iwai N; Nakamura H; Miyazu M; Katayama M; Kasai K
    Jpn J Antibiot; 1990 Sep; 43(9):1629-48. PubMed ID: 2262968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections.
    Childs SJ
    Am J Med; 1993 Mar; 94(3A):105S-107S. PubMed ID: 8452164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.